Establishment of two new predictive models for prostate cancer to determine whether to require prostate biopsy when the PSA level is in the diagnostic gray zone (4–10 ng ml(−1))

Our goal was to establish two new predictive models of prostate cancer to determine whether to require a prostate biopsy when the prostate-specific antigen level is in the diagnostic gray zone. A retrospective analysis of 197 patients undergoing prostate biopsy with prostate-specific antigens betwee...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jun, Wang, Zhi-Qian, Li, Min, Zhou, Ming-Yang, Yu, Yi-Fei, Zhan, Wei-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7155794/
https://www.ncbi.nlm.nih.gov/pubmed/31169140
http://dx.doi.org/10.4103/aja.aja_46_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7155794/
https://www.ncbi.nlm.nih.gov/pubmed/31169140
http://dx.doi.org/10.4103/aja.aja_46_19

Ejemplares similares